Stocktoria

MIRA PHARMACEUTICALS, INC. MIRA

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-08-03

MIRA PHARMACEUTICALS, INC. statistics & valuation

P / B4.1×

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Return on assets-94.1%-268.6%-242.9%-822.6%
Return on equity-100.5%-357.0%-273.9%1183.8%
Current ratio15.753.998.700.36

Source: SEC EDGAR filings · CIK 0001904286 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.